EUVIMEDObjevte EUVIMED
Multizentrische StudieOpen access · CC BY 4.0

Altered Pathogen Spectrum of Spontaneous Bacterial Peritonitis in Patients Treated With Proton Pump Inhibitors

Philip Kitchen, Sarah L Schütte, Tammo L Tergast iD, Benjamin Maasoumy, Leonie Braun, Ulrich Vor dem Esche, Georg Häcker, Marcus M Mücke, Marlene Reincke, Michael Schultheiss, Robert Thimme, Siegbert Rieg and 2 more

Alimentary Pharmacology & Therapeutics · 2026

DOI: 10.1111/apt.70593 ↗

At a glance

Multizentrische Studie in Alimentary Pharmacology & Therapeutics, 2026. Written by Philip Kitchen and 13 co-authors. Institution: Department of Medicine II, Medical Center University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany. Major MEDLINE topics: Proton Pump Inhibitors, Peritonitis, Liver Cirrhosis, Bacterial Infections. Cited 6 times so far (Crossref); 20 references. The full text is freely available (open access, CC BY 4.0).

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Background

Proton pump inhibitor (PPI) treatment leads to significant changes in the gut microbiota composition. We hypothesized that these alterations may transfer into distinct changes in the causative agents of spontaneous bacterial peritonitis (SBP) in patients with cirrhosis.

Aims

To investigate the impact of PPI treatment on the pathogen spectrum of SBP.

Methods

A total of 227 cirrhosis patients with culture‐positive SBP from two German tertiary care centers were included and the pathogen spectrum of SBP was analysed with respect to PPI treatment.

Results

In the PPI‐group, gram‐positive bacteria were significantly more common compared to the non‐PPI‐group (62.1% vs. 34.0%, p < 0.001). This involved increased abundances of Enterococcus spp. (22.0% vs. 8.0%), Streptococcus spp. (14.7% vs. 6.0%) and Staphylococcus aureus (15.8% vs. 8.0%). Importantly, more than half of the Enterococcus isolates were susceptible only to antibiotics with extended gram‐positive activity. Conversely, gram‐negative bacteria were significantly more frequent in the non‐PPI‐group compared to the PPI‐group (64.0% vs. 40.7%, p = 0.003), primarily due to a higher prevalence of E. coli (40.0% vs. 20.3%). In uni‐ and multivariable logistic regression analyses, PPI use was an independent predictor of gram‐positive SBP (OR 2.719, 95% CI 1.343–5.506, p = 0.005), adjusted for nosocomial infection (OR 2.609, 95% CI 1.464–4.650, p = 0.001) and Child‐Pugh score (OR 0.684, 0.552–0.848, p < 0.001).

Conclusions

PPI treatment is associated with increased abundances of gram‐positive pathogens, including Enterococcus spp., in culture‐positive SBP. This result can help guide empiric antibiotic therapy of SBP.

Subjects

MeSH terms (MEDLINE)

Proton Pump InhibitorsPeritonitisLiver CirrhosisBacterial InfectionsHumansFemaleMaleGram-Positive BacteriaMiddle AgedAnti-Bacterial AgentsAgedGram-Positive Bacterial InfectionsGram-Negative BacteriaEnterococcus

Author keywords

cirrhosisdecompensationinfection

Substances

Proton Pump InhibitorsAnti-Bacterial Agents

Authors and institutions

  • Department of Medicine II, Medical Center University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
  • Department of Gastroenterology, Hepatology, Infectious Diseases and Endocrinology, Hannover Medical School, Hannover, Germany.
  • German Center for Infection Research (DZIF), Hannover/Braunschweig, Germany.
  • Institute for Medical Microbiology and Hygiene, Medical Center University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
  • Department of Internal Medicine I, University Hospital, Goethe-University Frankfurt, Frankfurt am Main, Germany.
  • Berta-Ottenstein-Programme, Faculty of Medicine, University of Freiburg, Freiburg, Germany.

ORCID profiles: Tammo L Tergast, Dominik Bettinger

Cite

APA

Kitchen, P., Schütte, S. L., Tergast, T. L., Maasoumy, B., Braun, L., Esche, U. V. D., Häcker, G., Mücke, M. M., Reincke, M., Schultheiss, M., Thimme, R., Rieg, S., Bettinger, D., & Sturm, L. (2026). Altered Pathogen Spectrum of Spontaneous Bacterial Peritonitis in Patients Treated With Proton Pump Inhibitors. Alimentary Pharmacology & Therapeutics. https://doi.org/10.1111/apt.70593

Vancouver

Kitchen P, Schütte SL, Tergast TL, Maasoumy B, Braun L, Esche UVD, et al. Altered Pathogen Spectrum of Spontaneous Bacterial Peritonitis in Patients Treated With Proton Pump Inhibitors. Alimentary Pharmacology & Therapeutics. 2026. doi:10.1111/apt.70593

BibTeX
@article{Kitchen2026,
  author = {Kitchen, Philip and Schütte, Sarah L and Tergast, Tammo L and Maasoumy, Benjamin and Braun, Leonie and Esche, Ulrich Vor dem and Häcker, Georg and Mücke, Marcus M and Reincke, Marlene and Schultheiss, Michael and Thimme, Robert and Rieg, Siegbert and Bettinger, Dominik and Sturm, Lukas},
  title = {Altered Pathogen Spectrum of Spontaneous Bacterial Peritonitis in Patients Treated With Proton Pump Inhibitors},
  journal = {Alimentary Pharmacology & Therapeutics},
  year = {2026},
  doi = {10.1111/apt.70593}
}
Start for free →